BioCentury
ARTICLE | Clinical News

Minodronic acid hydrate regulatory update

August 8, 2011 7:00 AM UTC

In July, Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for monthly Bonoteo/Recalbon minodronic acid to treat osteoporosis. A once-daily formulation of the bisphosphonate is alre...